Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
After WHO trial failure, influential medical group advises against Gilead's remdesivir in COVID critical care: Reuters
Fierce Pharma
Fri, 11/13/20 - 01:28 pm
Gilead Sciences
remdesivir
Veklury
COVID-19
After Pfizer's vaccine data, analysts say COVID19 drugmakers face questions about long-term sales prospects
Fierce Pharma
Mon, 11/9/20 - 08:51 pm
Pfizer
BioNTech
Gilead Sciences
Eli Lilly
Regeneron
COVID-19
pharma stocks
vaccines
clinical trials
Will Gilead's Remdesivir Only Be a Short-Lived Success Story?
Motley Fool
Wed, 11/4/20 - 10:16 am
Gilead Sciences
remdesivir
COVID-19
Veklury
AASLD 2020 – Nash updates from Novo and Inventiva in focus
EP Vantage
Wed, 11/4/20 - 10:09 am
NASH
Novo Nordisk
Gilead Sciences
Inventiva
AASLD
selonsertib
Gilead should give up FDA voucher for remdesivir, patient advocates say
Beckers Hospital Review
Tue, 11/3/20 - 09:32 pm
Gilead Sciences
remdesivir
FDA
Public Citizen
Gilead stops 3 filgotinib trials pending FDA feedback on faltering JAK1 inhibitor
Fierce Biotech
Thu, 10/29/20 - 12:07 pm
Gilead Sciences
filgotinib
FDA
rheumatoid arthritis
Gilead Sales Up 18% in Q3, Thanks to Coronavirus Treatment Remdesivir
Motley Fool
Wed, 10/28/20 - 11:15 pm
Gilead Sciences
earnings
Veklury
remdesivir
COVID-19
WHO: Nations mulling Gilead's COVID drug should consider trial flop, too
Reuters
Sun, 10/25/20 - 11:26 pm
Gilead Sciences
remdesivir
WHO
clinical trials
COVID-19
Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus
Motley Fool
Thu, 10/22/20 - 11:29 pm
Gilead Sciences
remdesivir
FDA
COVID-19
Gilead announces new data on Biktarvy for the treatment of HIV in Black Americans
Pharmaceutical Business Review
Thu, 10/22/20 - 11:04 am
Gilead Sciences
Biktarvy
HIV
Massive Covid-19 Drug Trial Underscores Importance Of Controlled Clinical Studies
Forbes
Tue, 10/20/20 - 10:00 pm
WHO
clinical trials
COVID-19
remdesivir
Gilead Sciences
interferon
WHO: Remdesivir Does Not Substantially Affect COVID-19 Patient Mortality
Motley Fool
Fri, 10/16/20 - 11:16 am
Gilead Sciences
remdesivir
Veklury
COVID-19
clinical trials
EU makes 1 billion-euro bet on Gilead's COVID drug before trial results
Reuters
Tue, 10/13/20 - 10:00 pm
Europe
Gilead Sciences
COVID-19
remdesivir
Gilead and Galapagos's filgotinib shows sustained efficacy in ulcerative colitis study
Seeking Alpha
Tue, 10/13/20 - 11:17 am
filgotinib
Gilead Sciences
Galapagos
clinical trials
ulcerative colitis
Gilead's remdesivir shaved five days off COVID-19 recovery time, reduced risk of death in some
Yahoo/Reuters
Fri, 10/9/20 - 11:08 am
Gilead Sciences
remdesivir
FDA
COVID-19
Eli Lilly and Gilead’s combination cuts COVID-19 recovery time
Pharmaforum
Fri, 10/9/20 - 10:52 am
Eli Lilly
olumiant
baricitinib
Gilead Sciences
Veklury
remdesivir
COVID-19
clinical trials
NIH
Gilead rescues biopharma’s takeout scene
EP Vantage
Wed, 10/7/20 - 11:02 am
M&A
Gilead Sciences
Immunomedics
JNJ
Momenta Pharmaceuticals
Sanofi
Principia Biopharma
Nestle
Aimmune
Tizona Therapeutics
European Medicines Agency reviewing reports of kidney injury in patients taking Gilead's remdesivir
Beckers Hospital Review
Mon, 10/5/20 - 11:55 pm
EMA
Europe
Gilead Sciences
remdesivir
COVID-19
President Trump Begins Treatment With Remdesivir from Gilead Sciences
Motley Fool
Sun, 10/4/20 - 12:21 am
Donald Trump
COVID-19
Gilead Sciences
remdesivir
Veklury
Gilead to distribute COVID-19 drug Veklury in US, taking over from federal government
BioPharma Dive
Fri, 10/2/20 - 01:06 pm
Gilead Sciences
remdesivir
Veklury
COVID-19
Pages
« first
‹ previous
…
11
12
13
14
15
16
17
18
19
…
next ›
last »